Dhingra Ankur 4
4 · Summit Therapeutics Inc. · Filed Mar 8, 2023
Insider Transaction Report
Form 4
Dhingra Ankur
Chief Financial Officer
Transactions
- Purchase
Common Stock
2023-03-07$1.05/sh+196,362$206,180→ 234,558 total(indirect: By Trust)
Holdings
- 39,527
Common Stock
Footnotes (2)
- [F1]Represents the number of shares of Common Stock that the Reporting Person purchased in the Issuer's rights offering.
- [F2]The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.